Article
New insights into nucleic acid sensor AIM2: The potential benefit in targeted therapy for cancer
24 Jan 2024
Abstract excerpt
The AIM2 inflammasome represents a multifaceted oligomeric protein complex within the innate immune system, with the capacity to perceive double-stranded DNA (dsDNA) and engage in diverse physiological reactions and disease contexts, including cancer. While originally conceived as a discerning DNA sensor, AIM2 has demonstrated its capability to discern various nucleic acid variations, encompassing RNA and DNA-RNA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
